PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Breeze PR

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CVRx®, Inc. Introduces New Device Developed to Treat Uncontrollable Hypertension - Federally approved clinical study aims to prove device is a safe and effective way to control high blood pressure - CVRx.com
CVRx®, Inc. Introduces New Device Developed to Treat Uncontrollable Hypertension

 

NewswireToday - /newswire/ - Austin, TX, United States, 2008/04/24 - Federally approved clinical study aims to prove device is a safe and effective way to control high blood pressure - CVRx.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Hypertension affects 73 million Americans and is the leading cause of stroke, heart attack, heart failure and kidney disease according to the American Heart Association. About 25 percent of people with hypertension are unable to control their high blood pressure despite medication, adoption of a healthier lifestyle and other therapies.

To treat this condition, CVRx Inc., a private company, developed a device that stimulates the body’s natural system of lowering blood pressure currently being implanted in select patients across the United States.

Only a limited number of U.S. facilities can perform the surgical procedure involving the device that is currently being studied in an FDA-approved clinical trial.

“We’re very excited that we have the opportunity to offer the advanced technology to people at the end of the road whose doctors have exhausted every option to treat them” said Dr. Robert Feldtman, a cardiovascular surgeon responsible for implanting the device in qualifying Central Texas patients at Scott & White Hospital in Temple.

The device is designed to electrically activate the baroflex, the body’s natural blood pressure regulation system, to watch and control blood pressure. The procedure requires implanting a pulse generator, or battery, and wires under the collarbone, which send signals to the brain suggesting a blood pressure increase. The procedure is similar to a cardiac pacemaker implantation, Dr. Feldtman said.

Investigators at Scott & White Hospital are currently screening patients for participation in the Rheos Pivotal Trial. To qualify, patients must have persistent high blood pressure despite regular treatment with medications.

“Before the implant I took 17 pills a day and since I’ve had the device, I only need one,” said David K., one of 50 patients in the U.S. enrolled in the study. “I’m living proof that it doesn’t have to be that way.”

Sponsored by CVRx Inc., the trial aims to demonstrate that the product, the CVRx Rheos Baroflex Hypertension Therapy System, is a safe and effective treatment for patients to lower uncontrolled high blood pressure.

Clinical studies in Europe have been ongoing for the past four years and results show a significant reduction in implanted patients’ blood pressure according to reports from the European Society of Hypertension in 2007.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Breeze PR

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


CVRx®, Inc. Introduces New Device Developed to Treat Uncontrollable Hypertension

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mia Vieira - BreezePR.com 
512-236-1911 mia[.]breezemarketingaustin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Breeze PR securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Breeze PR / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55.0 Mn by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA
AFC Industries Joins HIMSS for its 56th Edition
Medical Companies Flock to Israel for R&D Support Infrastructure and Inorganic Growth Opportunities Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)